106 related articles for article (PubMed ID: 1917591)
1. HLA antigens influence resistance to lung carcinoma.
Romano PJ; Bartholomew M; Smith PJ; Kloszewski F; Stryker J; Houck J; Vesell ES
Hum Immunol; 1991 Aug; 31(4):236-40. PubMed ID: 1917591
[TBL] [Abstract][Full Text] [Related]
2. No association between HLA antigens and adenocarcinoma of the lung in non-smoking Chinese women in Hong Kong.
Lam WK; Hawkins BR; Kung IT; So SY
Br J Dis Chest; 1986 Oct; 80(4):370-4. PubMed ID: 3476147
[TBL] [Abstract][Full Text] [Related]
3. Histocompatibility antigens in small cell carcinoma of the lung.
Markman M; Braine HG; Abeloff MD
Cancer; 1984 Dec; 54(12):2943-5. PubMed ID: 6093986
[TBL] [Abstract][Full Text] [Related]
4. Association of differentiated thyroid carcinoma with HLA-DR7.
Sridama V; Hara Y; Fauchet R; DeGroot LJ
Cancer; 1985 Sep; 56(5):1086-8. PubMed ID: 3874685
[TBL] [Abstract][Full Text] [Related]
5. HLA alleles and lung cancer in a Turkish population.
Ozbek N; Birinci A; Karaoglanoglu O; Coban AY; Okumus B; Cakir S; Durupinar B
Ann Saudi Med; 2004; 24(2):106-11. PubMed ID: 15323271
[TBL] [Abstract][Full Text] [Related]
6. Do histocompatibility antigens influence the risk of head and neck carcinoma?
Houck JR; Romano PJ; Bartholomew M; Smith PJ; Kloszewski F; Vesell ES
Cancer; 1992 May; 69(9):2327-32. PubMed ID: 1373340
[TBL] [Abstract][Full Text] [Related]
7. Prolonged disease-free survival in bronchogenic carcinoma associated with HLA-Aw19 and HLA-B5. A two-year prospective study.
Rogentine CN; Dellon AL; Chretien PB
Cancer; 1977 Jun; 39(6):2345-7. PubMed ID: 872033
[TBL] [Abstract][Full Text] [Related]
8. HLA antigens and bronchogenic carcinoma.
Prazák J; Mĕricka O
Neoplasma; 1989; 36(5):599-602. PubMed ID: 2812153
[TBL] [Abstract][Full Text] [Related]
9. Relationship between carcinoembryonic antigen and major histocompatibility antigens on cultured human carcinoma cells.
Hirai T; Yamamoto H; Hamaoka T
J Immunol; 1980 Jun; 124(6):2765-71. PubMed ID: 6989905
[No Abstract] [Full Text] [Related]
10. Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer.
Doyle A; Martin WJ; Funa K; Gazdar A; Carney D; Martin SE; Linnoila I; Cuttitta F; Mulshine J; Bunn P
J Exp Med; 1985 May; 161(5):1135-51. PubMed ID: 2580935
[TBL] [Abstract][Full Text] [Related]
11. Enhanced expression in vivo of HLA-ABC antigens and beta 2-microglobulin on human lymphoid cells induced by human interferon-alpha in patients with lung cancer. Enhanced expression of class I major histocompatibility antigens prior to treatment.
Nissen MH; Plesner T; Larsen JK; Olesen BK; Ernst P
Clin Exp Immunol; 1985 Feb; 59(2):327-35. PubMed ID: 2983911
[TBL] [Abstract][Full Text] [Related]
12. [HLA-A, B antigens and bronchogenic pulmonary carcinoma].
Prazák J; Mĕricka O
Cas Lek Cesk; 1987 Aug; 126(34):1081-2. PubMed ID: 3478139
[No Abstract] [Full Text] [Related]
13. Haplotypes of human leukocyte antigens among patients with nasopharyngeal cancer in Greece.
Daniilidis M; Fountzilas G; Fleva A; Daniilidis J; Tourkantonis A
Oncology; 1997; 54(3):185-92. PubMed ID: 9143397
[TBL] [Abstract][Full Text] [Related]
14. Human leukocyte antigens as genetic markers in colorectal carcinoma.
Chatzipetrou MA; Tarassi KE; Konstadoulakis MM; Pappas HE; Zafirellis KD; Athanassiades TE; Papadopoulos SA; Panousopoulos DG; Golematis BC; Papasteriades CA
Dis Colon Rectum; 1999 Jan; 42(1):66-70. PubMed ID: 10211522
[TBL] [Abstract][Full Text] [Related]
15. HLA antigens and bronchogenic carcinoma in the Greek population.
Toumbis M; Zervas J; Anagnostopoulou O; Konstantopoulos K; Krimbeni G; Kotsovoulou V; Fessas F
Acta Oncol; 1991; 30(5):575-8. PubMed ID: 1654063
[TBL] [Abstract][Full Text] [Related]
16. HLA frequency and prognosis in lung cancer.
Ford CH; Newman CE; Mackintosh P
Br J Cancer; 1981 May; 43(5):610-4. PubMed ID: 6264939
[TBL] [Abstract][Full Text] [Related]
17. Altered HLA class I expression in non-small cell lung cancer is independent of c-myc activation.
Redondo M; Ruiz-Cabello F; Concha A; Cabrera T; Pérez-Ayala M; Oliva MR; Garrido F
Cancer Res; 1991 May; 51(9):2463-8. PubMed ID: 1849792
[TBL] [Abstract][Full Text] [Related]
18. Expression of myeloid and major histocompatibility antigens on small cell carcinoma of the lung cell lines analyzed by cytofluorography: modulation by gamma-interferon.
Ball ED; Sorenson GD; Pettengill OS
Cancer Res; 1986 May; 46(5):2335-9. PubMed ID: 3008987
[TBL] [Abstract][Full Text] [Related]
19. HLA and survival in lung cancer.
Mottironi VD; Banks SM; Pollara B; Rudofsky UH
Clin Immunol Immunopathol; 1987 Oct; 45(1):55-62. PubMed ID: 3476226
[TBL] [Abstract][Full Text] [Related]
20. Immunogenetic and immunologic studies of differentiated thyroid cancer.
Juhasz F; Boros P; Szegedi G; Balazs G; Suranyi P; Kraszits E; Stenszky V; Farid NR
Cancer; 1989 Apr; 63(7):1318-26. PubMed ID: 2784072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
